Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent (Q45875332)

17 December 2017

title

Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent (English)

1 reference

17 December 2017

1 reference

8

1 reference

17 December 2017

author name string

D M Appledorn

1

1 reference

17 December 2017

A Kiang

2

1 reference

17 December 2017

A McBride

3

1 reference

17 December 2017

H Jiang

4

1 reference

17 December 2017

S Seregin

5

1 reference

17 December 2017

J M Scott

6

1 reference

17 December 2017

R Stringer

7

1 reference

17 December 2017

M Hoban

9

1 reference

17 December 2017

M M Frank

10

1 reference

17 December 2017

A Amalfitano

11

1 reference

17 December 2017

language of work or name

1 reference

21 February 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

885-901

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2008.18

exact match

0 references

cites work

Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Current strategies and future directions for eluding adenoviral vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Biology of adenovirus and its use as a vector for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Rapid Kupffer cell death after intravenous injection of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

The induction of macrophage spreading by factor B of the properdin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Expression of the binding molecules for factor B and its fragment, Bb, of human complement on human monocytes after in vitro cultivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Tissue-specific mRNA expression profiles of human toll-like receptors and related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus type-5 entry and disassembly followed in living cells by FRET, fluorescence anisotropy, and FLIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Genomic DNA from mice: a comparison of recovery methods and tissue sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Augmented humoral and cellular immune responses induced by canine adenovirus type 1 DNA vaccine in BALB/c mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Infection of Mouse Liver by Human Adenovirus Type 5

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Human monocyte spreading induced by factor B of the alternative pathway of complement activation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.18

7 January 2021

Identifiers

DOI

10.1038/GT.2008.18

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017